Glioblastoma

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Tofacitinib in Recurrent GBM Patients

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Oral ONC201 in Adult Recurrent Glioblastoma

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

BIBF 1120 for Recurrent High-Grade Gliomas

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas

Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide

A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)

A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients

Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

AB154 Combined With AB122 for Recurrent Glioblastoma

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

HMPL-813 in Treating Patients With Glioblastoma

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

A Phase 0 Study of AZD1775 in Recurrent GBM Patients

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer